ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE backs use of Roche's Gazyvaro with bendustamine pharmatimes
May 14, 2020Patients with follicular lymphoma will now get NHS-funded treatment with Roche's Gazyvaro (binutuzumab)/bendamustine in England and Wales after cost regulators published guidelines backing its use in this setting.
Pharma Sources Insight January 2025
